Publications by authors named "Walter Toro"

Claim this Profile
C
Cost-utility analysis of newborn screening for spinal muscular atrophy in Japan.
Akira Hata, Akihito Uda, Satoru Tanaka, Diana Weidlich, Walter Toro

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Intervention and Speed-to-Effect in Spinal Muscular Atrophy Type 1 Following Onasemnogene Abeparvovec Gene Replacement Therapy: Results of aPost-Hoc Analysis of Pooled Clinical Study Data.
Walter Toro, Sandra P Reyna, Shannon Ritter, Anish Patel, Nayla Mumneh

Neurol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving Concept of Value in Health Economics and Outcomes Research: Emerging Tools for Innovation and Access to Cell and Gene Therapies for Rare Diseases.
Walter Toro, Min Yang, Anish Patel, Su Zhang, Omar Dabbous

Value Health· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risdiplam utilization, adherence, and associated health care costs for patients with spinal muscular atrophy: a United States retrospective claims database analysis.
Anish Patel, Walter Toro, Min Yang, Wei Song, Raj Desai

Orphanet J Rare Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment preferences in spinal muscular atrophy: A swing weighting study for caregivers of patients with SMA types 1 and 2.
Anish Patel, Walter Toro, Siobhan Bourke, Yemi Oluboyede, Sylvaine Barbier

PLoS One· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and Caregiver Outcomes After Onasemnogene Abeparvovec Treatment: Findings from the Cure SMA 2021 Membership Survey.
Walter Toro, Min Yang, Mihaela Georgieva, Annika Anderson, Nicole LaMarca

Adv Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Care Resource Utilization and Costs for Patients with Spinal Muscular Atrophy: Findings from a Retrospective US Claims Database Analysis.
Walter Toro, Min Yang, Mihaela Georgieva, Wei Song, Anish Patel

Adv Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Literature Review of Clinical and Economic Evidence for Spinal Muscular Atrophy.
Min Yang, Hiroyuki Awano, Satoru Tanaka, Walter Toro, Su Zhang

Adv Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis.
Marjolaine Gauthier-Loiselle, Martin Cloutier, Walter Toro, Anish Patel, Sherry Shi

Adv Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An updated cost-utility model for onasemnogene abeparvovec (Zolgensma®) in spinal muscular atrophy type 1 patients and comparison with evaluation by the Institute for Clinical and Effectiveness Review (ICER).
Rebecca Dean, Ivar Jensen, Phil Cyr, Beckley Miller, Benit Maru, Walter Toro

J Mark Access Health Policy· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Good Practices and Principles in Health Technology Assessment in Latin America.
Walter Toro, Diego Guarin

Value Health Reg Issues· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of multiple-criteria decision analysis (MCDA) to support healthcare decision-making FIFARMA, 2016.
Julia I Drake, Juan Carlos Trujillo de Hart, Clara Monleón, Walter Toro, Joice Valentim

J Mark Access Health Policy· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis